https://www.marketsandmarkets.com/MarketsandMarkets XML Feed en-us Copyright MarketsandMarkets 2/7/2026 6:21:47 PM GMT 2/7/2026 6:21:47 PM GMT 300 https://www.marketsandmarkets.com/ MarketsandMarkets – Market Research Company publishes about 120 business market researchreports a year across 10 main industries. Market research reports and industry trends analysis available from MarketsandMarkets.2/7/2026 6:21:47 PM GMT https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.htmlThe global proteomics market, valued at US$33.63 billion in 2024, stood at US$36.32 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$65.80 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification....1/27/2026 GMT https://www.marketsandmarkets.com/Market-Reports/north-america-epigenetics-market-8695913.htmlThe North America epigenetics market, valued at USD 0.84 billion in 2024, stood at USD 0.93 billion in 2025 and is projected to advance at a resilient CAGR of 13.8% from 2025 to 2030, culminating in a forecasted valuation of USD 1.78 billion by the end of the period. Growth of the North America epigenetics market is driven by a strong, well-funded life sciences ecosystem, with rising oncology and precision-medicine programs that rely on methylation and chromatin profiling....1/25/2026 GMT https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-therapeutics-market-41710113.htmlThe global oligonucleotide therapeutics market, valued at US$5.92 billion in 2024, stood at US$7.19 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2025 to 2030, culminating in a forecasted valuation of US$17.70 billion by the end of the period. The market is growing as more RNA-targeting therapies gain broader clinical acceptance. This increase is mainly driven by siRNAs and antisense candidates, supported by advances in delivery technologies like GalNAc conjugates and lipid nanoparticles....1/25/2026 GMT https://www.marketsandmarkets.com/Market-Reports/north-america-nucleic-acid-isolation-purification-market-63577630.htmlThe North America Nucleic Acid Isolation and Purification Market, valued at USD 2.80 billion in 2024, stood at USD 2.98 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of USD 4.64 billion by the end of the period. The growth of the North America nucleic acid isolation and purification market is largely dependent on the region's substantial number of molecular tests and quick acceptance of NGS-based workflows. ...1/25/2026 GMT https://www.marketsandmarkets.com/Market-Reports/predictive-biomarkers-market-97566514.htmlThe predictive clinical biomarkers market, valued at US$7.84 billion in 2024, stood at US$8.49 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$14.69 billion by the end of the period. he market for predictive clinical biomarkers is growing rapidly as the healthcare industry shifts toward personalized and predictive medicine. ...1/25/2026 GMT https://www.marketsandmarkets.com/Market-Reports/europe-epigenetics-market-252197128.htmlThe Europe epigenetics market, valued at USD 0.57 billion in 2024, stood at USD 0.63 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 1.22 billion by the end of the period. Growth is supported by a well-funded life sciences ecosystem, with rising oncology and precision medicine programs that increasingly rely on DNA methylation and chromatin profiling for biomarker discovery and translational research....1/25/2026 GMT https://www.marketsandmarkets.com/Market-Reports/biomaterials-393.htmlThe global biomaterials market, valued at US$45.15 billion in 2024, stood at US$48.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$68.93 billion by the end of the period. Biomaterials are specially crafted materials designed to interact safely with biological systems for medical applications. ...1/23/2026 GMT https://www.marketsandmarkets.com/Market-Reports/polymeric-biomaterials-market-164305934.htmlThe polymeric biomaterials market, valued at US$11.04 billion in 2024, stood at US$11.83 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$16.93 billion by the end of the period. The polymeric biomaterials market is experiencing rapid growth, driven by the advancement of personalized and targeted therapies. As hospitals and device manufacturers increasingly utilize engineered polymers for tailored implants, scaffolds, and drug-delivery systems, the market is witnessing significant growth....1/23/2026 GMT https://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.htmlThe next-generation sequencing market, valued at US$13.95 billion in 2024, stood at US$14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments....1/22/2026 GMT https://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.htmlThe global nucleic acid isolation and purification market, valued at US$6.67 billion in 2024, stood at US$7.10 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$10.99 billion by the end of the period. The global market for nucleic acid isolation and purification (NAIP) is expanding largely due to the increased use of PCR and NGS in clinical diagnostics and research. Laboratories globally require DNA/RNA of high purity and free of inhibitors in order to carry out reliable workflows for sequencing, oncology panels and routine molecular testing. ...1/20/2026 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-consumables-market-28497459.htmlThe pharmaceutical filtration consumables market, valued at US$11.19 billion in 2024, stood at US$11.96 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$18.03 billion by the end of the period. The pharmaceutical filtration consumables market is expanding rapidly, driven by factors such as the shift toward single-use technologies (SUTs) and disposables and advancements in membrane filter designs....1/14/2026 GMT https://www.marketsandmarkets.com/Market-Reports/asia-pacific-cell-culture-market-24517896.htmlThe Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing. ...1/13/2026 GMT https://www.marketsandmarkets.com/Market-Reports/asia-pacific-pharmaceutical-filtration-market-92818268.htmlThe Asia Pacific pharmaceutical filtration market, valued at USD 3.24 billion in 2024, stood at USD 3.50 billion in 2025 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2030, culminating in a forecasted valuation of USD 5.58 billion by the end of the period. The Asia Pacific pharmaceutical filtration market is experiencing growth, driven by quality regulations, rising demand for sterile drug production, and the increasing adoption of biologic therapies....1/13/2026 GMT https://www.marketsandmarkets.com/Market-Reports/europe-pharmaceutical-filtration-market-115776969.htmlThe Europe Pharmaceutical Filtration Market, valued at USD 3.81 billion in 2024, stood at USD 4.05 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of USD 5.95 billion by the end of the period. Pharmaceutical filtration is a process wherein solid and semi-solid particles present in a suspension are separated from a liquid or gas by employing membrane filters, such as filter sheets, cartridges & capsules, papers, depth filters, and others. ...1/13/2026 GMT https://www.marketsandmarkets.com/Market-Reports/genomic-biomarkers-market-48860286.htmlThe global genomic biomarkers market, valued at US$26.78 billion in 2024, stood at US$29.00 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2024 to 2030, culminating in a forecasted valuation of US$50.31 billion by the end of the period. Genomic biomarkers are measurable features of DNA and RNA used to aid disease diagnosis, characterize disease states, and guide therapeutic decision-making....1/8/2026 GMT https://www.marketsandmarkets.com/Market-Reports/human-microbiome-drugs-market-261309704.htmlThe human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions. ...1/8/2026 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-microfiltration-market-189639560.htmlThe global pharmaceutical microfiltration market, valued at US$5.66 billion in 2024, stood at US$6.13 billion in 2025 and is projected to advance at a resilient CAGR of 10.1% from 2025 to 2030, culminating in a forecasted valuation of US$9.94 billion by the end of the period....1/7/2026 GMT https://www.marketsandmarkets.com/Market-Reports/ngs-services-market-194102241.htmlThe next-generation sequencing services market, valued at US$3.40 billion in 2024, stood at US$3.80 billion in 2025 and is projected to advance at a resilient CAGR of 18.2% from 2025 to 2030, culminating in a forecasted valuation of US$8.77 billion by the end of the period. The global next-generation sequencing services market is growing as sequencing is used more widely in oncology, rare disease diagnostics, infectious disease monitoring, and broader precision medicine initiatives, with healthcare providers and biopharmaceutical companies increasingly outsourcing complex genomic workflows to specialized service partners. ...1/7/2026 GMT https://www.marketsandmarkets.com/Market-Reports/cell-culture-reagents-market-52737241.htmlThe cell culture reagents Market, valued at US$4.70 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted valuation of US$8.95 billion by the end of the period. The expansion of the global cell culture reagents market is primarily attributed to the global increase in biopharma manufacturing. ...1/6/2026 GMT https://www.marketsandmarkets.com/Market-Reports/cell-culture-vessels-market-75000041.htmlThe cell culture vessels market, valued at US$4.86 billion in 2024, stood at US$5.10 billion in 2025 and is projected to advance at a resilient CAGR of 9.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.03 billion by the end of the period. Growth in the global cell culture vessels market is tied to the expansion of biopharma manufacturing worldwide. Demand is rising for biologics such as monoclonal antibodies, vaccines, and recombinant proteins. ...1/5/2026 GMT https://www.marketsandmarkets.com/Market-Reports/single-molecule-real-time-smrt-sequencing-market-161993235.htmlThe Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs. ...12/20/2025 GMT https://www.marketsandmarkets.com/Market-Reports/human-microbiome-manufacturing-services-market-255565161.htmlThe global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services....12/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/north-america-human-microbiome-market-268083046.htmlNorth America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics. ...12/16/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.htmlThe global pharmaceutical filtration market, valued at US$13.41 billion in 2024, stood at US$14.35 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2024 to 2030, culminating in a forecasted valuation of US$21.75 billion by the end of the period....12/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.htmlThe global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period....12/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/patient-derived-xenograft-model-market-121598251.htmlThe global patient derived xenografts/PDX models market, valued at US$0.32 billion in 2024, stood at US$0.37 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation of US$0.66 billion by the end of the period. The major factors driving the growth in the PDX model market include the rising demand for clinically relevant preclinical models that closely replicate human tumor biology and therapeutic response....11/21/2025 GMT https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.htmlThe global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics....11/20/2025 GMT https://www.marketsandmarkets.com/Market-Reports/preimplantation-genetic-testing-market-605.htmlThe global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period....11/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-free-protein-synthesis-market-141393235.htmlThe global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems....10/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/molecular-cytogenetic-market-148469224.htmlThe global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing....10/13/2025 GMT https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.htmlThe global single-use bioprocessing market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. The single-use bioprocessing market is witnessing significant expansion due to the increasing adoption of disposable technologies in the biopharmaceutical sector....10/9/2025 GMT https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.htmlThe global 3D cell culture market, valued at US$1.18 billion in 2024, stood at US$1.29 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2030, culminating in a forecasted valuation of US$2.26 billion by the end of the period. The market growth is driven by the adoption of personalized medicine globally for multiple diseases and government support & funding for 3D cell culture....10/6/2025 GMT https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.htmlThe global neuromodulation market, valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to advance at a resilient CAGR of 9.4% from 2025 to 2030, culminating in a forecasted valuation of US$10.68 billion by the end of the period. Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life. ...9/15/2025 GMT https://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.htmlThe global immunohistochemistry market, valued at US$3.31 billion in 2024, stood at US$3.55 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$5.14 billion by the end of the period. The increasing number of cancer cases is one of the key factors driving the uptake of IHC products, which, in turn, leads to a greater need for accurate and efficient diagnostic tools such as IHC tests. ...9/15/2025 GMT https://www.marketsandmarkets.com/Market-Reports/ligase-enzymes-market-257141225.htmlThe global ligase enzymes market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.36 billion by the end of the period. The ligase enzymes market is growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering....9/12/2025 GMT https://www.marketsandmarkets.com/Market-Reports/human-microbiome-market-37621904.htmlThe global human microbiome market, valued at US$0.91 billion in 2024, stood at US$1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field....8/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/single-cell-sequencing-market-244864213.htmlThe global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$3.46 billion by the end of the period. This growth is driven by advancements in single-cell workflow, including more efficient cell isolation methods, improved library preparation kits, and high-throughput, cost-effective sequencing platforms....7/31/2025 GMT https://www.marketsandmarkets.com/Market-Reports/biobanking-devices-market-594.htmlThe global biobanking market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including growing focus on precision or personalized medicine, continuously expanding cell & gene therapy pipeline, and end-to-end automation for sample handling & storage....7/25/2025 GMT https://www.marketsandmarkets.com/Market-Reports/tangential-flow-filtration-market-72081607.htmlThe global tangential flow filtration market, valued at US$1.76 billion in 2024, stood at US$1.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.20 billion by the end of the period. Several factors contribute to the growth of the tangential flow filtration market, including the increasing adoption of single-use technologies and the rising demand for scalable & high-throughput purification systems in biologics manufacturing....7/22/2025 GMT https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.htmlThe global epigenetics market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 11.3% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period. The major factors driving the growth in epigenetics market includes reduced sequencing costs and accelerated turnaround times to improve access and affordability of epigenetic analysis....7/16/2025 GMT https://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.htmlThe global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering....7/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.htmlThe global flow cytometry market, valued at US$4.87 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2033, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine....7/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.htmlThe global cell culture market, valued at US$27.92 billion in 2024, stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market....7/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/biotechnology-ccontract-manufacturing-market-163964739.htmlThe global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth....7/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/in-situ-hybridization-market-212028829.htmlThe global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions....6/23/2025 GMT https://www.marketsandmarkets.com/Market-Reports/residual-dna-testing-market-89689614.htmlThe global residual DNA testing market, valued at US$0.27 billion in 2024, stood at US$0.28 billion in 2025 and is projected to advance at a resilient CAGR of 6.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.37 billion by the end of the period. The growth of the Asia Pacific residual DNA testing market is primarily due to increasing number of fundings and investments by pharmaceutical and biotechnology companies for the advancement of the healthcare sector. Additionally, emerging markets in the Asia Pacific is set to enhance the residual DNA testing market growth....6/19/2025 GMT https://www.marketsandmarkets.com/Market-Reports/exosome-research-product-market-224782498.htmlThe global exosome research market, valued at US$189.4 million in 2024, stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a forecasted valuation of US$480.6 million by the end of the period. The growth of the Asia Pacific exosome research market is primarily due to the growing biomedical industry, increasing life science research, and rising investments by pharmaceutical & biotechnology companies in this region....6/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.htmlThe global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology....6/3/2025 GMT https://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.htmlGlobal human leukocyte antigen (HLA) typing for transplant market valued at $1.0B in 2024, reached $1.1B in 2025, and is projected to grow at a robust 6.0% CAGR, hitting $1.4B by 2030. Market growth is driven by an increasing number of transplant procedures worldwide, a shift towards molecular assay technologies for HLA typing, favorable public-private investments and funding for research, and a strong focus by manufacturers on launching high-resolution HLA typing products....5/22/2025 GMT https://www.marketsandmarkets.com/Market-Reports/crispr-technology-market-134401204.htmlThe global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years....5/13/2025 GMT